cyc 202 has been researched along with anisomycin in 1 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (anisomycin) | Trials (anisomycin) | Recent Studies (post-2010) (anisomycin) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 1,357 | 0 | 319 |
| Protein | Taxonomy | cyc 202 (IC50) | anisomycin (IC50) |
|---|---|---|---|
| Glucose transporter | Leishmania mexicana | 0.225 | |
| Hexose transporter 1 | Plasmodium falciparum (malaria parasite P. falciparum) | 0.326 | |
| Solute carrier family 2, facilitated glucose transporter member 1 | Homo sapiens (human) | 0.321 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muresan, V; Muresan, Z | 1 |
1 other study(ies) available for cyc 202 and anisomycin
| Article | Year |
|---|---|
c-Jun NH2-terminal kinase-interacting protein-3 facilitates phosphorylation and controls localization of amyloid-beta precursor protein.
Topics: Adaptor Proteins, Signal Transducing; Amyloid beta-Protein Precursor; Animals; Anisomycin; Anthracenes; Blotting, Western; Cell Line; Chlorocebus aethiops; Enzyme Inhibitors; Gene Expression Regulation; Growth Inhibitors; Humans; Immunohistochemistry; Immunoprecipitation; Mice; Mitogen-Activated Protein Kinase 10; Models, Biological; Neurites; Neurons; Phosphorylation; Protein Binding; Purines; RNA, Small Interfering; Roscovitine; Transfection | 2005 |